Back to top

Eli Lilly & Co: (NYSE: LLY)

(U.S: NYSE) As of Apr 17, 2014 04:00 PM ET

 Add to portfolio

 ZacksTrade Now

$60.43 USD

+0.47 (0.78%)

Volume: 4,750,022

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

General Information

LILLY ELI & CO

LILLY CORPORATE CTR DROP CODE 1112

INDIANAPOLIS, IN 46285

Phone: 317-276-2000

Fax: 317-276-3492

Web: http://www.lilly.com

Email: cardwell_leanna_k@lilly.com

Industry LARGE CAP PHARMA
Sector Medical
Fiscal Year End December
Last Reported Quarter 3/31/2014
Next EPS Date 4/24/2014

EPS Information

Current Quarter EPS Consensus Estimate 0.70
Current Year EPS Consensus Estimate 2.80
Estimated Long-Term EPS Growth Rate 1.80
Next EPS Report Date 4/24/2014

Price and Volume Information

Zacks Rank
Yesterday's Close 59.96
52 Week High 60.46
52 Week Low 47.53
Beta 0.34
20 Day Moving Average 5,359,998.00
Target Price Consensus 60.09

LLY

% Price Change
4 Week 3.18
12 Week 9.57
YTD 17.57
% Price Change Relative to S&P 500
4 Week 3.57
12 Week 7.44
YTD 16.69
Share Information
Shares Outstanding (millions) 1,119.76
Market Capitalization (millions) 67,666.92
Short Ratio 4.56
Last Split Date 10/16/1997
Dividend Information
Dividend Yield 3.24%
Annual Dividend $1.96
Payout Ratio 0.47
Change in Payout Ratio NA
Last Dividend Payout / Amount 2/12/2014 / $0.49

Fundamental Ratios

P/E
P/E (F1) 21.55
Trailing 12 Months 14.56
PEG Ratio 12.20
EPS Growth
vs. Previous Year -12.94%
vs. Previous Quarter -33.33%
   
Sales Growth
vs. Previous Year -2.49%
vs. Previous Quarter 0.63%
   
Price Ratios
Price/Book 3.86
Price/Cash Flow 11.45
Price / Sales 2.93
ROE
3/31/14 NA
12/31/13 27.79
9/30/13 30.05
ROA
3/31/14 NA
12/31/13 13.35
9/30/13 13.88
Current Ratio
3/31/14 NA
12/31/13 1.47
9/30/13 1.63
Quick Ratio
3/31/14 NA
12/31/13 1.14
9/30/13 1.27
Operating Margin
3/31/14 NA
12/31/13 19.46
9/30/13 19.98
Net Margin
3/31/14 NA
12/31/13 20.27
9/30/13 20.56
Pre-Tax Margin
3/31/14 NA
12/31/13 25.48
9/30/13 25.76
Book Value
3/31/14 NA
12/31/13 15.66
9/30/13 15.00
Inventory Turnover
3/31/14 NA
12/31/13 1.75
9/30/13 1.75
Debt-to-Equity
3/31/14 NA
12/31/13 0.24
9/30/13 0.25
Debt to Capital
3/31/14 NA
12/31/13 19.23
9/30/13 20.15